21 November 2019GenericsRory O'Neill

LSPN Europe: new challenges for drug patent owners in Russia

Russian drug patent owners are being forced to come up with novel solutions to combat generic manufacturers trying to clear the way for competitor medicines.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

LSPN Europe: understand our business models, say in-house lawyers

26 November 2019 The best lawyers acting for life sciences companies make sure they fully understand their clients’ business models, said in-house counsel at Life Sciences Patent Network 2019.

Biotechnology

LSPN Europe: AIs should be named inventors, argues Dabus professor

21 November 2019 The team leader behind the world’s first artificial intelligence-generated patent application has said AI inventors will force major changes to the patent system.

Big Pharma

LSPN Europe: English contract law still ‘fit for purpose’ despite Brexit

21 November 2019 English law remains fit for purpose in international contracts in spite of Brexit, heard attendees at Life Sciences Patent Network Europe today, November 21.

More on this story

Big Pharma

LSPN Europe: understand our business models, say in-house lawyers

26 November 2019 The best lawyers acting for life sciences companies make sure they fully understand their clients’ business models, said in-house counsel at Life Sciences Patent Network 2019.

Biotechnology

LSPN Europe: AIs should be named inventors, argues Dabus professor

21 November 2019 The team leader behind the world’s first artificial intelligence-generated patent application has said AI inventors will force major changes to the patent system.

Big Pharma

LSPN Europe: English contract law still ‘fit for purpose’ despite Brexit

21 November 2019 English law remains fit for purpose in international contracts in spite of Brexit, heard attendees at Life Sciences Patent Network Europe today, November 21.

More on this story

Big Pharma

LSPN Europe: understand our business models, say in-house lawyers

26 November 2019 The best lawyers acting for life sciences companies make sure they fully understand their clients’ business models, said in-house counsel at Life Sciences Patent Network 2019.

Biotechnology

LSPN Europe: AIs should be named inventors, argues Dabus professor

21 November 2019 The team leader behind the world’s first artificial intelligence-generated patent application has said AI inventors will force major changes to the patent system.

Big Pharma

LSPN Europe: English contract law still ‘fit for purpose’ despite Brexit

21 November 2019 English law remains fit for purpose in international contracts in spite of Brexit, heard attendees at Life Sciences Patent Network Europe today, November 21.

More features

Life sciences leaders recognised at LSPN Awards USA 2025

UK-India trade deal is ‘a missed opportunity for UK pharma’, says industry body

LSPN: Counsel grapple with AI’s impact on training and critical thinking

'Nothing can stand in the way of our work': Ukraine resumes IP system

LSPN: Trump's policy storm causing chaos and confusion

Taylor Wessing expands in Europe with Paris team

LSPN: Using ‘the patentee’s friend’ in Section 112 claims

ResMed voids sleep apnoea tech patent at PTAB

LSPN Europe: new challenges for drug patent owners in Russia

More on this story

Editor's picks

Editor's picks

More on this story

More on this story

More features